IP Library Patent Application 13597509
Patent Application
App. No. 13/597,509

METHODS OF PREPARING 1-(4-((1R,2S,3R)-1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL)ETHANONE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/597,509
Abstract

Methods of preparing 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone and derivatives thereof are disclosed.

Claims (20)

1 . A method of preparing 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone, which comprises:

contacting 2-ethoxyacrylimidate with a weak acid salt of D-glucosamine to provide a first mixture;

contacting the first mixture with a base to provide a second mixture;

adding an aqueous acid to the second mixture to provide a third mixture;

maintaining the third mixture at a temperature of greater than 30° C. for at least 0.5 hours; and

isolating 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone from the third mixture.

2 . The method of claim 1 , wherein the weak acid salt of D-glucosamine is D-glucosamine acetate.

3 . The method of claim 2 , wherein the base is an alkaline or alkaline earth metal alkoxide, hydroxide, carbonate, phosphate, or trialkylamine.

4 . The method of claim 3 , wherein the base is methoxide.

5 . The method of claim 1 , wherein the first mixture is maintained at a temperature of greater than 10° C. for at least 0.5 hours.

6 . The method of claim 1 , wherein the second mixture is maintained at a temperature of greater than 5° C. for at least 1 hour.

7 . The method of claim 1 , wherein the third mixture is maintained at a temperature of greater than 50° C., for at least 0.5 hours.

8 . The method of claim 1 , wherein the aqueous acid has a pK a of from 0 to 10.

9 . The method of claim 8 , wherein the aqueous acid is formic, acetic, or trichloroacetic acid.

10 . The method of claim 9 , wherein the aqueous acid is acetic acid.

11 . The method of claim 1 , wherein the 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone is isolated by filtering a slurry prepared by concentrating, cooling and/or diluting the third mixture with water.

12 . (canceled)

13 . The method of claim 1 , wherein the 2-ethoxyacrylimidate is prepared by contacting 2-ethoxyacrylonitrile with an alcohol and an alkaline or alkaline earth metal alkoxide to provide a fourth mixture.

14 . The method of claim 13 , wherein the fourth mixture is maintained at a temperature of greater than 0° C. for at least 2 hours.

15 . 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone prepared by the method of claim 1 .

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →